Hepatitis C Virus Serine Protease Inhibitors: Current Progress and Future Challenges

E-ISSN： 1875-533x|8|8|919-932

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.8, Iss.8, 2001-07, pp. : 919-932

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel tripeptide inhibitors of hepatitis C virus NS3 serine protease

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 2, 2003-02 ,pp. : 267-272

Informa Healthcare

Access to resources Recommend Favorite

Peptidic Inhibitors of the Hepatitis C Virus Serine Protease within Non- Structural Protein 3

Current Pharmaceutical Design, Vol. 8, Iss. 28, 2002-12 ,pp. : 2533-2540

Bentham Science Publishers

Access to resources Recommend Favorite

Recent developments in the discovery of hepatitis C virus serine protease inhibitors – towards a new class of antiviral agents?

By Narjes Frank Koch Uwe Steinkühler Christian

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 2, 2003-02 ,pp. : 153-163

Informa Healthcare

Access to resources Recommend Favorite

Computer-Assisted Analysis of the Interactions of Macrocyclic Inhibitors with wild Type and Mutant D168A Hepatitis C Virus NS3 Serine Protease

Letters in Drug Design & Discovery, Vol. 3, Iss. 1, 2006-02 ,pp. : 17-28

Bentham Science Publishers

Access to resources Recommend Favorite

Novel protease and polymerase inhibitors for the treatment of hepatitis C virus infection

By Sheldon Julie Barreiro Pablo Vincent Vincent

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 8, 2007-08 ,pp. : 1171-1181

Informa Healthcare

Access to resources Recommend Favorite